Precise Biometrics AB financials
Precise Biometrics AB
54930047Z8TEBJTKYX74 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Cost of sales | SEK 23.8M | SEK 27.2M |
| Gross profit | SEK 63.1M | SEK 47.8M |
| Administrative expenses | SEK 13.8M | SEK 14.2M |
| Operating expenses | SEK 72.5M | SEK 74.3M |
| Operating profit (EBIT) | -SEK 9.4M | -SEK 26.5M |
| Net finance income / (cost) | SEK 630.0K | -SEK 291.0K |
| Finance costs | SEK 561.0K | SEK 1.1M |
| Profit before tax | -SEK 8.8M | -SEK 26.7M |
| Income tax expense | -SEK 351.0K | -SEK 346.0K |
| Profit for the year | -SEK 8.4M | -SEK 26.4M |
| — attributable to owners | -SEK 8.4M | -SEK 26.4M |
| Total comprehensive income | -SEK 8.2M | -SEK 26.5M |
| Per share | ||
| Basic EPS | SEK -0.11 | SEK -0.34 |
| Diluted EPS | SEK -0.11 | SEK -0.34 |
| Free cash flow / share | SEK 0.13 | SEK -0.15 |
| Cash flow statement | ||
| Net cash from operating activities | SEK 10.1M | -SEK 10.8M |
| Income taxes paid | SEK 22.0K | SEK 9.0K |
| Net cash from investing activities | -SEK 17.5M | -SEK 25.3M |
| Purchase of PP&E (capex) | SEK 370.0K | SEK 1.2M |
| Purchase of intangibles | SEK 11.0M | SEK 14.1M |
| Net cash from financing activities | -SEK 2.5M | SEK 37.3M |
| Lease liability payments | SEK 2.5M | SEK 2.3M |
| Net change in cash | -SEK 10.0M | SEK 1.2M |
| Balance sheet | ||
| Total assets | SEK 203.1M | SEK 212.7M |
| Non-current assets | SEK 135.4M | SEK 139.2M |
| Property, plant & equipment | SEK 1.6M | SEK 2.4M |
| Intangible assets & goodwill | SEK 124.7M | SEK 132.8M |
| Current assets | SEK 67.7M | SEK 73.5M |
| Inventories | SEK 242.0K | SEK 359.0K |
| Trade & other receivables | SEK 23.8M | SEK 19.2M |
| Cash & equivalents | SEK 37.7M | SEK 47.5M |
| Total equity | SEK 151.2M | SEK 159.3M |
| — attributable to owners | SEK 151.2M | SEK 159.3M |
| Non-current liabilities | SEK 16.3M | SEK 17.5M |
| Current liabilities | SEK 35.6M | SEK 35.9M |
| Deferred tax liabilities | SEK 3.6M | SEK 4.0M |
| Derived metrics | ||
| Free cash flow | SEK 9.7M | -SEK 12.0M |
| Operating margin | -10.8% | -35.2% |
| Net margin | -9.7% | -35.2% |
| Return on equity | -5.6% | -16.6% |
| Cash conversion ratio | -1.19× | 0.41× |
| Capex coverage | 27.18× | -8.86× |
| Other reported items | ||
| Additional Paidin Capital | SEK 917.8M | SEK 917.8M |
| Adjustments For Decrease Increase In Inventories | SEK 117.0K | -SEK 48.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -SEK 4.1M | -SEK 7.1M |
| Adjustments For Depreciation and Amortisation Expense | SEK 22.8M | SEK 24.8M |
| Adjustments For Increase Decrease In Trade and Other Payables | -SEK 71.0K | -SEK 2.4M |
| Cash Flows From Used In Operations Before Changes In Working Capital | SEK 14.1M | -SEK 1.2M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | SEK 6.2M | SEK 10.0M |
| Comprehensive Income Attributable To Owners of Parent | -SEK 8.2M | -SEK 26.5M |
| Current Accruals and Current Deferred Income Including Current Contract Liabilities | SEK 22.9M | SEK 22.4M |
| Current Prepaid Expenses | SEK 2.8M | SEK 2.9M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | SEK 164.0K | -SEK 83.0K |
| Equity and Liabilities | SEK 203.1M | SEK 212.7M |
| Finance Income | SEK 1.2M | SEK 825.0K |
| Increase Decrease In Working Capital | SEK 4.1M | SEK 9.5M |
| Increase Decrease Through Sharebased Payment Transactions | SEK 2.0K | SEK 3.0K |
| Increase Decrease Through Transactions With Owners | SEK 2.0K | SEK 39.5M |
| Issue of Equity | — | SEK 49.5M |
| Issued Capital | SEK 23.5M | SEK 23.5M |
| Other Adjustments For Noncash Items | SEK 134.0K | SEK 75.0K |
| Other Comprehensive Income | SEK 274.0K | -SEK 127.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | SEK 274.0K | -SEK 127.0K |
| Other Current Liabilities | SEK 2.2M | SEK 2.3M |
| Other Current Receivables | SEK 3.1M | SEK 3.5M |
| Other Operating Income Expense | SEK 1.3M | -SEK 606.0K |
| Payments For Share Issue Costs | SEK 0 | SEK 10.0M |
| Payments To Acquire Or Redeem Entitys Shares | SEK 3.0K | SEK 0 |
| Proceeds From Issuing Shares | SEK 0 | SEK 49.5M |
| Research and Development Expense | SEK 27.0M | SEK 32.1M |
| Reserve of Exchange Differences On Translation | SEK 4.7M | SEK 4.4M |
| Retained Earnings | -SEK 794.9M | -SEK 786.5M |
| Revenue From Contracts With Customers | SEK 86.9M | SEK 75.1M |
| Rightofuse Assets That Do Not Meet Definition of Investment Property | SEK 9.1M | SEK 4.0M |
| Selling Expense | SEK 33.0M | SEK 27.4M |
| Share Issue Related Cost | — | SEK 10.0M |
| Trade and Other Current Payables To Trade Suppliers | SEK 2.3M | SEK 2.7M |
Every line item above is a fact tagged in Precise Biometrics AB's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.